Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
about
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.Simultaneous medullary and papillary thyroid cancer: a novel entity?Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a cautionary noteCalcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma.Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association.Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinomaStimulated calcitonin cut-offs by different tests.Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).Early diagnosis of medullary thyroid carcinoma: is systematic calcitonin screening appropriate in patients with nodular thyroid disease?Presentation of points of general discussion and voting among the speakers of the European Thyroid Association-Cancer Research Network (ETA-CRN) meeting in Lisbon, 2009, entitled "European comments to ATA medullary thyroid cancer guidelines".Prophylactic "First-Step" Central Neck Dissection (Level 6) Does Not Increase Morbidity After (Total) Thyroidectomy.Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma.Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.Solid cell nests of the thyroid gland: morphological, immunohistochemical and genetic features.Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test"
P2860
Q30317867-F52155BA-7202-4DD9-B888-2F01D0013EAEQ30318389-4A624F72-E86D-4795-A34F-6D42D6E9EE15Q34245750-1DEDEBD2-C585-4A7B-8233-559765490083Q35139360-233976CE-F5E7-4E97-9ABF-621415FAD39BQ36690542-3A3DDD96-3A22-4CAC-923D-49F8F62E6482Q36690582-6E3DC544-BA78-4C76-BB91-F0E699929BB7Q37261277-BAD0C44C-3DA9-4B00-BBDD-ABF5EE735C22Q37290965-4A1D80DD-E433-4063-B7C6-469B3F677624Q38168128-AE699A60-ED0B-4E57-ABC5-B029E53EBFB3Q39510131-CDAA2F5A-C7A8-40E1-BE75-49D6B78371F1Q41042765-88855271-9068-4B82-8839-A5AF0874FE87Q41288073-4ADBD3BA-D102-482C-A085-299A7794555DQ42440955-0C060BFC-9817-49B3-97EA-D3703ED6F27BQ42441942-200CE4D6-52B1-4E9D-BF24-911B0F9BB7A0Q42462455-D5EDA09D-4BC7-4474-A9BD-A18CDD714500Q48138466-E22D86A1-C44A-416A-9267-5D7311E83DCFQ59133711-9E5AAD41-555D-4F62-836A-0AFDF74A241D
P2860
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
@en
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
@nl
type
label
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
@en
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
@nl
prefLabel
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
@en
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
@nl
P2093
P356
P1476
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
@en
P2093
P304
P356
10.1677/ERC-08-0059
P577
2008-11-05T00:00:00Z